Hancock Whitney’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-3,133
Closed -$2M 792
2025
Q3
$2M Buy
3,133
+240
+8% +$146K 0.04% 299
2025
Q2
$1.55M Buy
+2,893
New +$1.38M 0.03% 335
2024
Q3
Sell
-427
Closed -$208K 628
2024
Q2
$208K Buy
427
+20
+5% +$10K 0.01% 583
2024
Q1
$220K Buy
+407
New +$222K 0.01% 607
2021
Q3
Sell
-976
Closed -$616K 738
2021
Q2
$616K Sell
976
-19
-2% -$10.5K 0.02% 505
2021
Q1
$487K Buy
+995
New +$499K 0.02% 555

Other funds holding IDXX

Hancock Whitney's IDXX Position: Q4 2025 in Review

Hancock Whitney sold out of Idexx Laboratories (IDXX) in Q4 2025, closing a stake of 3,133 shares — an estimated $2M sold.

Hancock Whitney first reported a position in IDXX in Q1 2021 and held it in 6 quarters. The position peaked at $2M in Q3 2025. 1,386 funds tracked by Wall St. Rank hold IDXX as of Q4 2025.

  • Hancock Whitney reported no remaining Idexx Laboratories position as of Q4 2025 after selling out during the quarter.
  • Hancock Whitney sold 3,133 Idexx Laboratories shares in Q4 2025, an estimated $2M.
  • Hancock Whitney first reported a position in Idexx Laboratories in Q1 2021 and held it in 6 quarters.
  • Hancock Whitney's Idexx Laboratories position peaked at $2M in Q3 2025.
  • 1,386 funds tracked by Wall St. Rank held Idexx Laboratories as of Q4 2025.

Based on Hancock Whitney's 13F filing for Q4 2025, filed 17 Feb 2026.